Can the prophylactic use of raloxifene, a selective estrogen-receptor modulator, prevent bone mineral loss and fractures in women with diagnosed osteoporosis or vertebral fractures?

B. Ettinger, D. M. Black, B. H. Mitlak, J. A. Rosenfeld

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)186-188
Number of pages3
JournalWestern Journal of Medicine
Volume173
Issue number3
DOIs
StatePublished - 2000

ASJC Scopus subject areas

  • Medicine(all)

Cite this